Indian lab files for clearance in Brazil of covid-19 vax
Brazil's National Health Surveillance Agency (Anvisa) has announced it had received this week the request for registration of a COVID-19 vaccine that uses recombinant protein technology.
The application has been submitted by Zalika Farmacêutica Ltda., the local representatives in Brazil of India's Serum Institute, the developers of the Covovax drug, which is intended for people over 18 years of age.
”The protocol was received on Wednesday (April 27) and is already being evaluated by the technical areas involved. The deadline for the Agency's analysis is 60 days,” Anvisa said Friday in a statement.
According to Oswaldo Cruz Foundation (FioCruz) sources quoted by Agencia Brasil, recombinant vaccines use the technology of a non-replicating viral vector of chimpanzee adenovirus. The genome is genetically manipulated so that it can no longer replicate and then they insert the SARS-CoV-2 spike protein gene. Once obtained, the adenoviruses are amplified in large numbers using modified cells to allow amplification of the adenovirus and production of the vaccine in disposable bioreactors. These adenoviruses are purified, concentrated, and stabilized to make up the final vaccine. The vaccine goes through rigorous quality control before being sent to health clinics.
USA: FDA restricts J&J’s COVID-19 vaccine due to blood clot risk
USA: FDA restricts J&J’s COVID-19 vaccine due to blood clot risk
www.UMMnews.org
WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that…
“Global Influenza Vaccines Market and Forecasts 2024 – 2032” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the global influenza vaccines market. The report also provides up-to-date historical market size data for the period 2018 – 2023 and an illustrative forecast to 2032 covering key market aspects like market value, volume analysis, and trends for influenza vaccines globally.
booster dose | booster dose in india | Covid 19 Vaccine | Covid 19 | healthy | who | Corona cases | coronavirus covid 19 india
WHO said this big thing about booster dose, know what is the opinion of the expert?
Booster Dose: Corona cases are continuously increasing in the country. In such a situation, there is a continuous debate about booster doses. In such a situation, do you know from experts whether you can take a booster dose again and again?
Image Source: WHO who_booster_dose
Corona cases are continuously…
Corona cases in the country cross 21 thousand again, the number of active cases is close to the figure of 1.5 lakh
Corona cases in the country cross 21 thousand again, the number of active cases is close to the figure of 1.5 lakh
Covid-19 Update in India: The increasing cases of corona across the world have raised concern once again. In India too, the number of patients infected with carona is increasing rapidly. Once again more than 21 thousand cases have been reported from Corona in the country. In the last 24 hours, 21,880 new cases of carona were reported. At the same time, 60 people lost their lives. The number of…
Coronavirus: First day of free boosters sees nearly 95% jump in offtake
Coronavirus: First day of free boosters sees nearly 95% jump in offtake
Day 1 of the free boosters for all adults saw an almost 95 per cent jump with over 1.49 mn precaution shots administered across all cohorts including healthcare and frontline workers compared to 766,786 precaution doses administered the day before. India had administered 2 million doses of vaccines till 7 pm across all age groups on Friday, and the share of precaution doses were high at 74.5 per…
तेज रफ़्तार से बढ़ रहा है कोरोना, 24 घंटों में आए इतने हजार मामले
तेज रफ़्तार से बढ़ रहा है कोरोना, 24 घंटों में आए इतने हजार मामले
Image Source : INDIA TV
Corona Update
Highlights
पिछले 24 घंटों 4.32% की दर से हुई है कोरोना केसों में बढ़ोत्तरी
पिछले 24 घंटों में 13 संक्रमितों ने अपनी जान भी गंवाई है
पिछले 24 घंटों में 13,029 लोग कोविड के संक्रमण से उबरे हैं
Corona Update: कोरोना के मामले फिर से बढ़ने लगे हैं। देश में बढ़ते संक्रमण और तेज होती रफ्तार अब डराने लगी है। देश में पिछले 24 घंटे में कोरोना से संक्रमण के 17336 नए…
As Small States Lead Covid-19 Booster Dose Coverage, A Look at Why the Drive Failed to Take Off in India
As Small States Lead Covid-19 Booster Dose Coverage, A Look at Why the Drive Failed to Take Off in India
Small states and Union Territories, including Ladakh, Sikkim, Delhi and Lakshadweep, are leading in the coverage of booster doses in India, data shows.
According to data collated by ORF, a Delhi-based independent think tank, Andhra Pradesh, Bihar, Delhi and Haryana have seen the most growth in the uptake of booster doses between April 15 and June 10.
Precaution dose for the 18-59 years category…
The BA.4 and BA.5 Omicron sub-variants are making their presence felt across various areas in the country with the daily Covid tally now showing a rise in the country. When contacted, Dr Soumya Swaminathan, WHO chief scientist, told The Indian Express that it could be the start of a mini wave.
“The sub-variants that are emerging are more transmissible than the original Omicron BA.1 and there is a…